A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show the treatment is safe and can significantly improve vision, even in severely ...

Neurons from grafted stem cells contain intrinsic codes for navigating and forming connections, which may improve cell therapy for a brain short-circuited by stroke. Some parts of our bodies bounce ...

Every year, millions of lives are suddenly, swiftly transformed by a stroke, which occurs when a blood vessel traveling towards the brain becomes obstructed, causing neurons to die off. Strokes are ...

Kylie Jenner, Kim Kardashian, and Chris Hemsworth are publicly embracing stem cell therapy as Hollywood’s newest treatment ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

Two early-stage clinical trials demonstrate the safety and potential effectiveness of stem cell therapies to treat Parkinson’s disease (PD), the second most common neurological disease worldwide. PD ...

During the height of New York City’s COVID-19 lockdown, a small group of people with Parkinson’s disease arrived at Memorial Sloan Kettering Cancer Center for an experimental neurosurgical procedure: ...

Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it ...

Add Yahoo as a preferred source to see more of our stories on Google. Kim and Khloé Kardashian had stem cell therapy in Mexico overseen by Dr. Adeel Khan. (Photo illustration: Yahoo News; photos: Kim ...

Scientists from the German Cancer Research Center (DKFZ) and the HI-STEM* Stem Cell Institute have deciphered a key mechanism ...

Katie has a PhD in maths, specializing in the intersection of dynamical systems and number theory. She reports on topics from maths and history to society and animals. Katie has a PhD in maths, ...

People who received an infusion of stem cells shortly after a heart attack were less likely to develop heart failure than those treated with standard care, according to the largest such trial to date.